1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Treating Cushing's Disease in Dogs Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Trilostane
  • 1.3.3 Selegiline
  • 1.3.4 Mitotane
  • 1.3.5 Other
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Treating Cushing's Disease in Dogs Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Veterinary Clinic
  • 1.4.3 Vet Hospital
  • 1.4.4 Other
• 1.5 Global Treating Cushing's Disease in Dogs Market Size & Forecast
  • 1.5.1 Global Treating Cushing's Disease in Dogs Consumption Value (2021 & 2025 & 2032)
  • 1.5.2 Global Treating Cushing's Disease in Dogs Sales Quantity (2021-2032)
  • 1.5.3 Global Treating Cushing's Disease in Dogs Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Dechra Pharmaceuticals
  • 2.1.1 Dechra Pharmaceuticals Details
  • 2.1.2 Dechra Pharmaceuticals Major Business
  • 2.1.3 Dechra Pharmaceuticals Treating Cushing's Disease in Dogs Product and Services
  • 2.1.4 Dechra Pharmaceuticals Treating Cushing's Disease in Dogs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Dechra Pharmaceuticals Recent Developments/Updates
• 2.2 Zoetis
  • 2.2.1 Zoetis Details
  • 2.2.2 Zoetis Major Business
  • 2.2.3 Zoetis Treating Cushing's Disease in Dogs Product and Services
  • 2.2.4 Zoetis Treating Cushing's Disease in Dogs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Zoetis Recent Developments/Updates
• 2.3 HRA Pharma Rare Diseases
  • 2.3.1 HRA Pharma Rare Diseases Details
  • 2.3.2 HRA Pharma Rare Diseases Major Business
  • 2.3.3 HRA Pharma Rare Diseases Treating Cushing's Disease in Dogs Product and Services
  • 2.3.4 HRA Pharma Rare Diseases Treating Cushing's Disease in Dogs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 HRA Pharma Rare Diseases Recent Developments/Updates

3 Competitive Environment: Treating Cushing's Disease in Dogs by Manufacturer

• 3.1 Global Treating Cushing's Disease in Dogs Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Treating Cushing's Disease in Dogs Revenue by Manufacturer (2021-2026)
• 3.3 Global Treating Cushing's Disease in Dogs Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Treating Cushing's Disease in Dogs by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Treating Cushing's Disease in Dogs Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Treating Cushing's Disease in Dogs Manufacturer Market Share in 2025
• 3.5 Treating Cushing's Disease in Dogs Market: Overall Company Footprint Analysis
  • 3.5.1 Treating Cushing's Disease in Dogs Market: Region Footprint
  • 3.5.2 Treating Cushing's Disease in Dogs Market: Company Product Type Footprint
  • 3.5.3 Treating Cushing's Disease in Dogs Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Treating Cushing's Disease in Dogs Market Size by Region
  • 4.1.1 Global Treating Cushing's Disease in Dogs Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Treating Cushing's Disease in Dogs Consumption Value by Region (2021-2032)
  • 4.1.3 Global Treating Cushing's Disease in Dogs Average Price by Region (2021-2032)
• 4.2 North America Treating Cushing's Disease in Dogs Consumption Value (2021-2032)
• 4.3 Europe Treating Cushing's Disease in Dogs Consumption Value (2021-2032)
• 4.4 Asia-Pacific Treating Cushing's Disease in Dogs Consumption Value (2021-2032)
• 4.5 South America Treating Cushing's Disease in Dogs Consumption Value (2021-2032)
• 4.6 Middle East & Africa Treating Cushing's Disease in Dogs Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Treating Cushing's Disease in Dogs Sales Quantity by Type (2021-2032)
• 5.2 Global Treating Cushing's Disease in Dogs Consumption Value by Type (2021-2032)
• 5.3 Global Treating Cushing's Disease in Dogs Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Treating Cushing's Disease in Dogs Sales Quantity by Application (2021-2032)
• 6.2 Global Treating Cushing's Disease in Dogs Consumption Value by Application (2021-2032)
• 6.3 Global Treating Cushing's Disease in Dogs Average Price by Application (2021-2032)

7 North America

• 7.1 North America Treating Cushing's Disease in Dogs Sales Quantity by Type (2021-2032)
• 7.2 North America Treating Cushing's Disease in Dogs Sales Quantity by Application (2021-2032)
• 7.3 North America Treating Cushing's Disease in Dogs Market Size by Country
  • 7.3.1 North America Treating Cushing's Disease in Dogs Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Treating Cushing's Disease in Dogs Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Treating Cushing's Disease in Dogs Sales Quantity by Type (2021-2032)
• 8.2 Europe Treating Cushing's Disease in Dogs Sales Quantity by Application (2021-2032)
• 8.3 Europe Treating Cushing's Disease in Dogs Market Size by Country
  • 8.3.1 Europe Treating Cushing's Disease in Dogs Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Treating Cushing's Disease in Dogs Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Treating Cushing's Disease in Dogs Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Treating Cushing's Disease in Dogs Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Treating Cushing's Disease in Dogs Market Size by Region
  • 9.3.1 Asia-Pacific Treating Cushing's Disease in Dogs Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Treating Cushing's Disease in Dogs Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Treating Cushing's Disease in Dogs Sales Quantity by Type (2021-2032)
• 10.2 South America Treating Cushing's Disease in Dogs Sales Quantity by Application (2021-2032)
• 10.3 South America Treating Cushing's Disease in Dogs Market Size by Country
  • 10.3.1 South America Treating Cushing's Disease in Dogs Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Treating Cushing's Disease in Dogs Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Treating Cushing's Disease in Dogs Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Treating Cushing's Disease in Dogs Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Treating Cushing's Disease in Dogs Market Size by Country
  • 11.3.1 Middle East & Africa Treating Cushing's Disease in Dogs Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Treating Cushing's Disease in Dogs Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Treating Cushing's Disease in Dogs Market Drivers
• 12.2 Treating Cushing's Disease in Dogs Market Restraints
• 12.3 Treating Cushing's Disease in Dogs Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Treating Cushing's Disease in Dogs and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Treating Cushing's Disease in Dogs
• 13.3 Treating Cushing's Disease in Dogs Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Treating Cushing's Disease in Dogs Typical Distributors
• 14.3 Treating Cushing's Disease in Dogs Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Treating Cushing's Disease in Dogs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Cushing's disease in dogs, also known as hyperadrenocorticism, is a condition characterized by excessive production of cortisol, which can lead to various health issues.Common drugs include trilostane, which inhibits cortisol synthesis, and mitotane, which selectively destroys adrenal cortex cells.
The treatment of Cushing's disease in dogs has evolved significantly over the years, with a growing emphasis on targeted therapies and individualized care. Advances in veterinary medicine have led to the development of more effective and safer medications, such as trilostane and newer formulations of mitotane, which allow for better control of cortisol levels with fewer side effects. Additionally, the use of diagnostic imaging and hormone testing has improved the ability to accurately diagnose and monitor the disease. Researchers are also exploring novel therapies, including gene therapy and minimally invasive surgical options, indicating a trend toward more comprehensive and personalized approaches in managing this complex condition.
This report is a detailed and comprehensive analysis for global Treating Cushing's Disease in Dogs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Treating Cushing's Disease in Dogs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Treating Cushing's Disease in Dogs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Treating Cushing's Disease in Dogs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Treating Cushing's Disease in Dogs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Treating Cushing's Disease in Dogs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Treating Cushing's Disease in Dogs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dechra Pharmaceuticals, Zoetis, HRA Pharma Rare Diseases, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Treating Cushing's Disease in Dogs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Trilostane
Selegiline
Mitotane
Other
Market segment by Application
Veterinary Clinic
Vet Hospital
Other
Major players covered
Dechra Pharmaceuticals
Zoetis
HRA Pharma Rare Diseases
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Treating Cushing's Disease in Dogs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Treating Cushing's Disease in Dogs, with price, sales quantity, revenue, and global market share of Treating Cushing's Disease in Dogs from 2021 to 2026.
Chapter 3, the Treating Cushing's Disease in Dogs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Treating Cushing's Disease in Dogs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Treating Cushing's Disease in Dogs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Treating Cushing's Disease in Dogs.
Chapter 14 and 15, to describe Treating Cushing's Disease in Dogs sales channel, distributors, customers, research findings and conclusion.